Rising medicinal use On 1 July, 2023, the Therapeutic Merchandise Administration amended its scheduling of copyright substances to enable the prescription of psilocybin for use in copyright assisted psychotherapy for cure-resistant melancholy. Trials as for their success and basic safety in man